Krever Commission

Krever Commission The Krever Commission was a public inquiry established in Canada in 1993 to investigate widespread contamination of the blood supply with human immunodeficiency virus and hepatitis C virus during the 1970s–1990s period. Chaired by Justice[Do not link] and widely reported across Toronto Star, Globe and Mail, and broadcast on Canadian Broadcasting Corporation, the inquiry had major implications for health care institutions such as the Canadian Red Cross and national agencies like the Health Canada predecessor structures and the Canadian Blood Services successor arrangements. The Commission's work intersected with civil litigation in provincial courts such as the Ontario Superior Court of Justice and prompted legislative responses from the Parliament of Canada.

Background and Establishment

The inquiry was launched amid public outcry after investigative reports in outlets including Toronto Star, Globe and Mail, and coverage by Canadian Broadcasting Corporation and advocacy by patient groups like AIDS Coalition to Unleash Power-style activists and survivor organizations. Political pressure in the House of Commons of Canada and from provincial premiers such as leaders from Ontario and Quebec led Prime Minister Kim Campbell’s successor and cabinet ministers from the Liberal Party of Canada to authorize a federal public inquiry. The public health crisis implicated national institutions including the Canadian Red Cross and federal agencies with oversight ties to the Department of National Health and Welfare and raised questions about interactions with international suppliers like plasma fractionators associated with companies linked to cross-border exchanges with the United States and France.

Mandate and Investigation Scope

The Commission's terms of reference instructed examination of the roles of the Canadian Red Cross, provincial health ministries such as the Ontario Ministry of Health and the Quebec Ministry of Health and Social Services, federal departments like Health Canada, and regulatory frameworks including those influenced by the Food and Drug Administration and international standards from bodies akin to the World Health Organization. It investigated procurement practices, screening of donors at collection centers in cities such as Montreal, Toronto, and Winnipeg, and distribution networks reaching hospitals like Toronto General Hospital and clinics tied to university centres such as McGill University Health Centre and University Health Network. The scope covered epidemiological evidence involving human immunodeficiency virus transmission, laboratory testing by institutions comparable to provincial public health labs, and liability issues considered in connection with firms in the private sector and insurance mechanisms overseen by provincial agencies in British Columbia, Alberta, and elsewhere.

Findings and Conclusions

The Commission concluded that contamination resulted from failures at multiple levels, including inadequate donor screening practices influenced by procurement choices that sourced blood products from high-risk populations and plasma pools associated with firms in the United States and Europe. It found systemic shortcomings in oversight by agencies analogous to Health Canada and pointed to delayed implementation of testing for HIV and hepatitis C virus that had been available or under development in laboratories in Europe and North America. The report criticized organizational cultures at the Canadian Red Cross and provincial health authorities for prioritizing supply continuity over safety, noting regulatory gaps relative to standards advocated by the World Health Organization and scientific communities at institutions like Centers for Disease Control and Prevention and major universities such as University of Toronto and McGill University. The Commission documented human tragedies involving recipients treated at hospitals including Toronto General Hospital and noted extensive civil actions in courts such as the Supreme Court of Canada-linked jurisprudence and provincial civil tribunals.

Recommendations and Policy Impact

The Commission recommended creation of a national, independent blood authority to replace the role played by the Canadian Red Cross in blood collection and distribution, increased transparency including public disclosure practices used by agencies like Health Canada, and compensation schemes for infected recipients administered through federal-provincial arrangements in the Canada Health Act environment. It urged adoption of modern screening technologies and procurement reforms to avoid reliance on risky international plasma sources, aligning Canadian practice with standards from the World Health Organization and technical guidance from the Centers for Disease Control and Prevention. The recommendations prompted debates in the House of Commons of Canada, influenced provincial executive councils and premiers, and led to legal settlements negotiated with plaintiff groups represented before provincial superior courts.

Implementation and Legacy

Following the report, the federal and provincial governments implemented major institutional reforms including establishment of a national non-profit authority that assumed responsibilities formerly held by the Canadian Red Cross and restructured oversight frameworks within Health Canada and provincial ministries of health. Compensation programs and settlement funds were negotiated involving the Government of Canada and provincial governments, with adjudication sometimes proceeding through administrative tribunals and provincial courts. The inquiry's legacy includes impacts on public health policy, donor screening standards used by blood services in Canada and influence on international practice discussed at forums like the World Health Assembly and collaborations with agencies akin to the Centers for Disease Control and Prevention. The Commission remains cited in debates over public inquiries, institutional accountability in healthcare settings including major hospitals and research universities, and in scholarship produced by Canadian legal scholars at institutions such as University of Toronto Faculty of Law and McGill University Faculty of Law.

Category:Public inquiries in Canada